SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
438Oops, wrong thread - sorry for that last post.Ian@SI-8/23/2007
437My thanks to DB and to GSK :-) I sold 60 PUT contracts yesterday afternoon. UsIan@SI-8/23/2007
436Acadia Pharmaceuticals Rated New `Buy' at Deutsche Bank:ACAD US 2007-08-21 1mopgcw-8/23/2007
435Int J Neuropsychopharmacol. 2007 Aug 21;:1-9 [Epub ahead of print] PET analysisscaram(o)uche-8/22/2007
434[N-desmethylclozapine enhances nitric oxide's cardiac vagal facilitation in tuck-8/21/2007
433Wyeth schizophrenia drug not approvable. Wyeth Pharmaceuticals and Solvay Pharmsim1-8/10/2007
432J Am Coll Cardiol. 2007 Aug 7;50(6):528-36. Epub 2007 Jul 23. Pharmacological scaram(o)uche-8/9/2007
4314th UPDATE: AstraZeneca 2Q Down On Higher Costs; Lifts Outlook 10:37 AM EDT Julymopgcw-7/26/2007
430Acadia Pharmaceuticals - ACAD-NNM Market Outperform - Price 13.68 on July 16 by mopgcw-7/22/2007
429AstraZeneca seen frontrunner to buy Acadia drug Fri Jul 20, 2007 7:04AM EDT By sim1-7/20/2007
428>>>> Eur J Pharmacol. 2007 Jun 29; [Epub ahead of print] AC260584 tuck-7/17/2007
427>>ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Ctuck-7/16/2007
426Ahead of the Bell: Acadia Tuesday July 10, 8:47 am ET Acadia Pharmaceuticals Ratsim1-7/10/2007
425Pharmacol Ther. 2007 May 21; [Epub ahead of print] Pharmacology of N-desmethylscaram(o)uche-6/27/2007
424[n-desmethylclozapine partially activated dopamine D(3) receptor-mediated ERK 1/tuck-6/27/2007
423[Pharmacology of N-desmethylclozapine] Review article; abstract is fluff. One tuck-6/26/2007
422ACADIA Pharmaceuticals Initiates Phase IIb Clinical Trial with ACP-104 in Patiensim1-6/26/2007
421Cramer features ACAD on mad money tonight. Almost as positive as when he first Ian@SI-6/5/2007
420[ACP-104: Partial agonist actions of N-desmethylclozapine at dopamine D(2L) recetuck-5/31/2007
419[Prevalence and nature of side effects during clozapine maintenance treatment antuck-5/25/2007
418[ACP-103 Improves The Antipsychotic Efficacy And Side Effect Profile Of Haloperituck-5/25/2007
417[ACP 104: Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on intuck-5/23/2007
416>>ACADIA Pharmaceuticals Reports First Quarter 2007 Financial Results Tuestuck-5/8/2007
415Mol Pharmacol. 2007 May 2; [Epub ahead of print] Identification of the atypicalscaram(o)uche-5/4/2007
414[Pharmacokinetics, Tolerability, and Safety of ACP-103 Following Single or Multituck-5/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News